Actavis plc (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a ...
Today, the Centers for Medicare and Medicaid Services (CMS) issued findings that show slower growth in health spending since the implementation of the Affordable Care Act. This successful cost control is consistent with data demonstrating ...
Tags: Centers for Medicare and Medicaid Services, health spending
A network of children's hospitals, data partners, and specialty networks led by The Children's Hospital of Philadelphia was recently approved for an award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand ...
Actavis plc (NYSE: ACT) today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and ...
Tags: Actavis, Warner Chilcott Company LLC, Abbreviated New Drug Application
Today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal ...
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...
Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations
Canada-based ImStar Therapeutics has announced the selection of IMS-088 as its lead drug candidate for the treatment of amyotrophic lateral sclerosis. IMS-088 is a novel, small-molecule drug that stems from the discovery of a new target ...
SuperGroup Plc provides a trading update covering the 13-week period to 27 October 2013 and the 26-week period to 27 October 2013. Group Total Group sales for ...
Tags: Supergroup, Apparel
Rubicon Technology Inc of Bensenville, IL, USA (which makes monocrystalline sapphire substrates and products for the LED, RFIC, semiconductor and optical industries) has launched what it claims is the first commercial line of large-diameter ...
Tags: Rubicon Sapphire substrates, LED, Electrical, Electronics
US-based specialty pharmaceutical firm Par Pharmaceutical has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clonidine hydrochloride (HCl) extended-release (ER) ...
Tags: Par Pharmaceutical, Medicine
LED lighting, LED chip, lamp and lighting maker Cree Inc of Durham, NC, USA has earned ENERGY STAR qualification for its soft-white Cree LED Bulbs. ENERGY STAR qualification signifies that these Cree LED bulbs now qualify for incentive ...
Tags: LED Bulbs, Electronics
The next big opportunity for growth in the global solar business lies in small, emerging markets where photovoltaic (PV) installations are forecast to rise at about triple the global average during the period from 2012-2017. Annual ...
The firm said that its new ‘Direct Dispenser’ is a fast, automatic labour-saving way of dispensing process colours, coatings and ready-mixed colours that need no blending directly to the packaging printing press. Suited for ...
Tags: Direct Dispenser, Inks
After years of oversupply, the supply and demand for solar devices is returning to a state of balance. Because of this, IMS Research is reiterating its forecast that global capital spending by producers of photovoltaic (PV) modules, cells, ...